Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Enanta Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 155 | 160 | +5 |
| Shares | 20.2M | 19.7M | −520.8K (−2.6%) |
| Value | $956.3M | $1.02B | +$66.0M (+6.9%) |
New holders (21)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (16)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Paradigm Biocapital Advisors LP | 148,216 | $7.01M |
| Bank of Montreal | 58,920 | $2.69M |
| Marshall Wace, LLP | 50,160 | $2.37M |
| Acadian Asset Management LLC | 42,640 | $2.02M |
| Point72 Asset Management, L.P. | 28,700 | $1.36M |
| Acuta Capital Partners, LLC | 27,500 | $1.30M |
| SEI Investments Co | 13,942 | $659.0K |
| Caxton Associates LP | 13,843 | $654.0K |
| PDT Partners, LLC | 11,597 | $548.0K |
| Clearstead Advisors, LLC | 5,064 | $239.0K |
| Blueshift Asset Management, LLC | 4,398 | $208.0K |
| Quantamental Technologies LLC | 4,334 | $205.0K |
| DekaBank Deutsche Girozentrale | 3,950 | $183.0K |
| Robeco Institutional Asset Management B.V. | 861 | $41.0K |
| Captrust Financial Advisors | 870 | $41.0K |
| Sageworth Trust Co of South Dakota | 10 | $0 |